TherapeuticsMD, Inc. (TXMD) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | -7.84M | -2.46M | -4.67M | -33.17M | 59.77M | 10.41M | 115.81M | -29.53M | -39.56M | -38.22M | -26.53M |
| Operating CF Margin % | 129.28% | 41.21% | 133.42% | 34.03% | 174.55% | 1.8% | -33.82% | 382.05% | 3.51% | -1561.95% | 4632.08% | -1068.65% | -7974.76% | 5188.54% | 49.79% | 405.48% | -152.72% | -211.79% | -150.45% | -115.35% |
| Operating CF Growth % | 36.44% | 2966.67% | 665.41% | -63.76% | 6136.36% | 100.15% | 92.46% | 119.14% | 100.03% | -113.12% | -123.57% | -104.03% | -12.36% | 251.1% | 127.25% | 536.48% | 23.07% | -30.46% | -12.26% | 52.58% |
| Net Income | 103K | -612K | 50K | 545K | -636K | 252K | -567K | -1.09M | -809K | -1.54M | -1.43M | -2.41M | -2.31M | -33.22M | -14.63M | -14.87M | -17.88M | -42.96M | -47.42M | -42.65M |
| Depreciation & Amortization | 325K | 906K | 96K | 96K | 95K | 100K | 96K | 180K | 133K | 637K | 130K | 128K | 27K | -1.99M | 273K | 282K | 329K | 1M | 1.03M | 1.04M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 24K | 0 | 96K | 0 | 0 | 0 | 0 | 0 | 2.98M | 0 | 0 | 0 | 5.35M | 7.31M | 2.51M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6K | -486K | 295K | 160K | 252K | -903K | 115K | 936K | 537K | -3.48M | 4.41M | -857K | -23.99M | 97M | -3.02M | 138.75M | -9.6M | 1.52M | 2.44M | 1.84M |
| Working Capital Changes | 514K | 560K | 605K | -477K | 975K | 539K | 171K | 772K | 150K | -3.46M | -5.56M | -1.53M | -6.9M | -5M | 27.79M | -8.36M | -2.38M | -4.46M | -1.59M | 10.73M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19K | 0 | 13.65M | -11.09M | 489K | 1.23M | -4.02M | 23K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -551K | 2.82M | -1.42M | -260K | -368K | -228K |
| Change in Payables | -340K | 114K | -87K | 174K | -82K | 0 | 91K | 4K | 112K | -669K | -812K | -818K | 164K | 4.97M | -430K | -358K | -502K | 726K | 5.03M | 4.25M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81.16M | -126K | 111K | -212K | -1.51M | -182K | -89K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21K | 7K | -76K | -212K | -1.51M | 70K | -41K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 1561.95% | - | - | - | 1.82% | 0.03% | 0.27% | 1.1% | 8.11% | 0.28% | 0.18% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81.14M | -133K | 187K | 0 | 0 | -252K | -48K |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -1.11M | 1.15M | 1.11M | -129.95M | 1.74M | -120M | -5M | 1.35M | 31.82M | 428K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -94.43M | 0 | -120M | -5M | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M | -1K | 1.15M | 0 | -33.23M | 2.47M | 0 | 0 | 1.23M | 31.95M | 163K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.11M | 1K | 1.11M | -2.29M | -729K | 0 | 0 | 119K | -131K | 265K |
| Net Change in Cash | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | -5.84M | -3.56M | -3.52M | -21.08M | 10.99M | 777K | 7.17M | -34.74M | -39.72M | -6.58M | -26.19M |
| Free Cash Flow | 936K | 368K | 1.05M | 324K | 686K | 12K | -185K | 894K | 11K | 0 | -2.46M | -4.67M | -33.17M | 59.73M | 10.41M | 115.83M | -29.57M | -41.07M | -38.41M | -26.62M |
| FCF Margin % | 129.28% | 41.21% | 133.42% | 34.03% | 174.55% | 1.8% | -33.82% | 382.05% | 3.51% | - | 4632.08% | -1068.65% | -7974.76% | 5185.33% | 49.79% | 405.55% | -152.94% | -219.9% | -151.17% | -115.74% |
| FCF Growth % | 36.44% | 2966.67% | 665.41% | -63.76% | 6136.36% | - | 92.46% | 119.14% | 100.03% | -100% | -123.57% | -104.03% | -12.2% | 245.44% | 127.12% | 535.1% | 23.09% | -33.28% | -11.93% | 52.76% |
| FCF per Share | 0.08 | 0.03 | 0.09 | 0.03 | 0.06 | 0.00 | -0.02 | 0.08 | 0.00 | - | -0.23 | -0.46 | -3.40 | 6.38 | 1.12 | 12.79 | -3.43 | -4.81 | -4.55 | -3.38 |
| FCF Conversion (FCF/Net Income) | 9.85x | -0.59x | 6.88x | 0.59x | -1.05x | 0.05x | 0.30x | -0.82x | -0.01x | 8.88x | 0.73x | 1.93x | 9.21x | -1.80x | -0.36x | 1.03x | 0.41x | 0.92x | 0.81x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.17M | 0 | 0 | 0 | 5.39M | 5.39M | 5.33M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |